Navigation Links
Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies

t limited to, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    Media Contact:                    Investor Contact:

     David Schull or Wendy Lau         Andreas Marathovouniotis

     Noonan Russo                      Noonan Russo

     212-845-4271                      212-845-4253

              

     

david.schull@eurorscg.com andreas.marathis@eurorscg.com wendy.lau1@eurorscg.com

CONTACT: Media: David Schull, , or Wendy Lau,, +1-212-845-4271, or Investors: AndreasMarathovouniotis, +1-212-845-4253, , all ofNoonan Russo, for Alfacell Corporation david.schull@eurorscg.com wendy.lau1@eurorscg.com andreas.marathis@eurorscg.com

Web site: http://www.alfacell.com/http://www.wiley.com/

Ticker Symbol: (NASDAQ-NMS:ACEL)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media C
'"/>




Page: 1 2 3 4

Related medicine technology :

1. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
2. Preclinical Data Show Alfacells Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells
3. Researchers Identify Intracellular Pathway of Alfacells Onconase
4. In vivo Study Results Demonstrating Potential of Alfacells Onconase for Treatment of Non-Small Cell Lung Cancer Published in Anticancer Research
5. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
6. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
9. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
10. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
11. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:11/26/2014)... , Nov. 26, 2014 Zynerba Pharmaceuticals ... development of innovative transdermal synthetic cannabinoid treatments, today announced ... 26th Annual Healthcare Conference 2014. The conference will be ... Palace in New York . Zynerba,s ... at 4:50 pm on Tuesday, December 2. ...
(Date:11/26/2014)... and NEW YORK and ... As the leading distributor of market intelligence, MarketResearch.com is ... report by IQ4I Research and Consultancy focusing on the ... more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... -- Reinforcing its commitment to enabling confident diagnosis through ... AEX: PHIA) today announced 510(k) clearance from the ... IQon Spectral CT , presenting an entirely new approach ... new dimension to Computed Tomography (CT) imaging, delivering anatomical ... on their material content within a single scan. The ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3
(Date:11/28/2014)... "Most of my life, I have suffered from foot issues ... from Findlay, Ohio. "I thought that there had to be ... inspired me to invent this accessory." , She developed the ... an injured foot. The sling makes it easier for the ... The design redistributes weight so that the individual does not ...
(Date:11/28/2014)... ARTAS robotic hair transplant surgical procedures ... PAI Medical Group hair transplant surgeons Chris Pawlinga, M.D. ... hair transplant procedure in the Brentwood office on Monday, ... in Tennessee and one of only three medical centers ... robotic hair transplantation. Patients benefit from this minimally invasive, ...
(Date:11/28/2014)... 2014 Nipomo Family Dentistry , ... recently opened its doors at 195 N. Thompson St., ... preventative care like teeth cleanings, oral exams, fillings, implants ... teeth whitening (and Kor whitening), laser whitening, gum tissue ... Family Dentistry’s five-person team also takes a philanthropic approach ...
(Date:11/27/2014)... Ericdress.com today announced a site-wide promotion for the coming ... all its clothing, shoes and other fashion accessories. The Special ... only. , At the special offer, orders above $79.99 can ... an extra $10 discount. Moreover, orders above $59 come with ... new collection of 2015 evening dresses to its global customers. ...
(Date:11/27/2014)... 2014 Recently, DressVe , the well-known ... Monday Sales, which are valid during Nov. 29 – Dec. ... on these new dresses, up to 90% off. In addition, ... to view more at http://www.dressve.com/ , Dresses that ... great way to showcase somebody’s personality and figure. The designers ...
Breaking Medicine News(10 mins):Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 3Health News:Ericdress.com Special Monday Sales Are Ready For Everyone 2Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2
... ) AMDL, Inc. (Amex: ADL ), a ... today the closing of the first tranche of a private placement offering of ... In this first closing, AMDL sold $1,077,500 of 12% senior notes at ... the completion of a bank or credit facility of not less than $8 ...
... First in UK to Perform Study Utilizing Pathwork Tissue of Origin ... 9 Pathwork Diagnostics, a molecular diagnostics company focused on oncology, ... Trust in London. Guy,s and St Thomas, will be the first ... the Pathwork(R) Tissue of Origin Test, which aids in the diagnosis ...
... ,Allscripts announced today that Edge Health Solutions, Inc. ... 1,000 physicians and,dentists who use Edge practice management ... OS X(R). , ... Canada-based Edge provides US and Canadian physicians and ...
... Vein Thrombosis (DVT) Prophylaxis in Hospitals , ... Inc., in coordination with the North American Thrombosis Forum (NATF), ... provides national recognition to hospitals that have made a significant ... , , With today,s ...
... RIDGE, N.J. and OMAHA, Neb., Dec. 9 Hooper Holmes ... Mears has been appointed President of the Company,s Omaha, Nebraska ... of services to insurance underwriters. , , ... in the insurance industry over the past 20 years. ...
... Annual Children,s Flu Vaccination Day to Help Increase Vaccination Rates and Reduce Flu-Related Illnesses ... , , To view the Multimedia News Release, ... , News Facts , , ... Families Fighting Flu (FFF) , together with the Centers for Disease Control ...
Cached Medicine News:Health News:AMDL Inc. Announces Closing of Private Placement Senior Notes 2Health News:AMDL Inc. Announces Closing of Private Placement Senior Notes 3Health News:Pathwork Diagnostics Collaborates With Guy's and St Thomas' on Tissue of Origin Test Validation in the UK 2Health News:Pathwork Diagnostics Collaborates With Guy's and St Thomas' on Tissue of Origin Test Validation in the UK 3Health News:Edge Health Solutions Selects Allscripts ePrescribe for Mac OS X Medical and Dental Platform 2Health News:Edge Health Solutions Selects Allscripts ePrescribe for Mac OS X Medical and Dental Platform 3Health News:Edge Health Solutions Selects Allscripts ePrescribe for Mac OS X Medical and Dental Platform 4Health News:Edge Health Solutions Selects Allscripts ePrescribe for Mac OS X Medical and Dental Platform 5Health News:Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations 2Health News:Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations 3Health News:Hooper Holmes Appoints Marcus Mears President of Underwriting Solutions Division 2Health News:Hooper Holmes Appoints Marcus Mears President of Underwriting Solutions Division 3Health News:Photo: Families Fighting Flu and CDC Encourage Parents to Vaccinate Kids Against Flu 2Health News:Photo: Families Fighting Flu and CDC Encourage Parents to Vaccinate Kids Against Flu 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: